Hypothalamus-pituitary-adrenal Axis Involves in Anti-Viral Ability Through Regulation of Immune Response in Piglets Infected by Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus.

Jie Tong,Ying Yu,Linlin Zheng,Chong Zhang,Yabin Tu,Yonggang Liu,Jianan Wu,Hai Li,Shujie Wang,Chenggang Jiang,En-Min Zhou,Gang Wang,Xuehui Cai
DOI: https://doi.org/10.1186/s12917-018-1414-3
2015-01-01
Abstract:Background: The highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) has been responsible for several viral attacks in the Asian porcine industry, since the first outbreak in China in 2006. During the early stages of the HP-PRRSV infection, high levels of proinflammatory cytokines are noted in the host peripheral blood, which are accompanied by severe lesions in the lungs and immune system organs; these are considered as the greatest contributors to the overall disease burden. We hypothesized that the anti-PRRSV response in piglets might be mediated by the hypothalamus-pituitary-adrenal (HPA) axis, which led to a decrease in the psycho-neuroendocrinological manifestation of HP-PRRSV etiology via immune response regulation. Results: We investigated the regulation of the HPA axis in HP-PRRSV-infected piglets that were treated with 1 mg/kg body weight (b.w.)/day mifepristone (RU486) or 2 mg/kg b.w./day dexamethasone (DEX). Both RU486 and DEX enhanced the disease status of the piglets infected by the HP-PRRSV HuN4 strain, resulting in high mortality and more severe pathological changes in the lungs. Conclusions: HP-PRRSV infection activates the HPA axis, and artificial regulation of the immune-endocrine system enhances disease severity in HP-PRRSV-infected piglets. Thus, DEX and RU486 should be avoided in the clinical treatment of HP-PRRS.
What problem does this paper attempt to address?